1.
Fleury I, Laverdure E. Bispecific antibodies and chimeric antigen receptor (CAR) T-cell therapy for indolent lymphoma. Can Hematol Today [Internet]. 2023 Nov. 6 [cited 2024 Jun. 19];2(3):5-11. Available from: https://canadianhematologytoday.com/article/view/2-3-fleury_laverdure